Korean J Blood Transfus.  1997 May;8(1):59-64.

Post-transfusion Survival of SAG-M Additive Solution Preserved Red Blood Cells

Affiliations
  • 1Blood Research Institute, Korea Red Cross, Seoul, Korea.
  • 2Department of Clinical Pathology*, College of Medicine, Korea University, Seoul, Korea.
  • 3Department of Nuclear Medicine**, Capital Armed Forces General Hospital.

Abstract

BACKGROUDNS: In Korea, CPDA-1 solution is currently used for blood preservation and by this anticoagulant solution, RBCs can be preserved for up to 35 days at the refrigerate temperature. RBC additive solutions (AS-1, AS-3, AS-5, SAG-M, SAG-PM) are widely used in the other countries for longer preservation of RBCs (42 days). We studied the survival of transfused RBCs preserved in SAG-M additive solution.
MATERIALS AND METHODS
400 mL of whole blood were collected from 8 healthy volunteers, Plasma was removed by centrifugation separation method at 2,960g, 10 minute and replaced by 100 mL of SAG-M additive solution. Autologous transfusions were done in two groups on day 20 and 42 with Na51CrO4 (Dupont, USA) labelled RBCs. After 3, 10, 15, 20, 30 minutes and 1, 2, 24 hours, 20 days, the venous blood samples were collected from the volunteers, and their radioactivities were measured by the Gamma-counter (Cobra II, Germany), and 24 hour survival rate were calculated by Moroff's method.
RESULTS
The mean 24 hour survival rate was 89.0% in 20 days preservation group and 71.8% in 42 days preservation group. The mean half life of transfused RBCs were 27.8 days (n=2)and 24.3 days (n=4) in 20 days and 42 days preservation group, respectively. No complications were observed during the study period.
CONCLUSIONS
The RBCs preserved in SAG-M additive solution were near within allowable survival rates for transfusion.

Keyword

RBCs Survival; SAG-M; Additive solution

MeSH Terms

Blood Preservation
Centrifugation
Erythrocytes*
Half-Life
Healthy Volunteers
Korea
Plasma
Radioactivity
Survival Rate
Volunteers
Full Text Links
  • KJBT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr